Compile Data Set for Download or QSAR
maximum 50k data
Found 194 with Last Name = 'baik' and Initial = 'tg'
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355874(N-(4-((5-(3-amino-4-methoxy)-5-fluorophenyl)pyrrol...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355868(N-(4-((5-(5-((dimethylamino)methyl)-2-fluorophenyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355872(N-(3-fluoro-4-((5-(3-((methylamino)methyl)phenyl)p...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355871(N-(4-((5-(3-amino-2-methyl)-5-fluorophenyl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355870(N-(4-((5-(3-amino-4-methyl)-5-fluorophenyl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355869(N-(4-((5-(3-((dimethylamino)methyl)-5-fluorophenyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355876(N-(4-((5-(3-cyanomethylphenyl)pyrrolo[1,2-b]pyrida...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355873(N-(4-((5-(3-((ethylamino)methyl)phenyl)pyrrolo[1,2...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355867(N-(4-((5-(2-chloro-5-((dimethylamino)methyl)phenyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355866(N-(4-((5-(3-(ethylamino)phenyl)pyrrolo[1,2-b]pyrid...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355865(N-(4-((5-(3-aminomethylphenyl)pyrrolo[1,2-b]pyrida...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355864(N-(4-((5-(3-amino-5-cyanophenyl)pyrrolo[1,2-b]pyri...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355863(N-(4-((5-(3-((dimethylamino)methyl)phenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355862(N-(4-((5-(3-((dimethylamino)methyl)phenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355861(4-ethoxy-N-(3-fluoro-4-((5-(3-aminophenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355860(4-ethoxy-N-(3-fluoro-4-((5-(3-morpholin-4-carbonyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355859(4-ethoxy-N-(3-fluoro-4-((5-(pyrimidin-5-yl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355858(N-(3-fluoro-4-((5-(3-(1-hydroxyethyl)phenyl)pyrrol...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355857(4-ethoxy-N-(3-fluoro-4-((5-(3-(1-hydroxyethyl)phen...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355856(4-ethoxy-N-(3-fluoro-4-((5-(3-(2-hydroxypropan-2-y...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355855(N-(3-fluoro-4-((5-(3-hydroxymethyl)phenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355854(4-ethoxy-N-(3-fluoro-4-((5-(3-formylphenyl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355853(4-ethoxy-N-(3-fluoro-4-((5-pyridin-4-yl)pyrrolo[1,...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor(Homo sapiens (Human))
The Asan Foundation

US Patent
LigandPNGBDBM355875(N-(4-((5-(5-amino-2-fluoro)-5-fluorophenyl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM50429896(CHEMBL2332918)
Affinity DataIC50:  89nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429897(CHEMBL2333379)
Affinity DataIC50:  89nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429895(CHEMBL2333375)
Affinity DataIC50:  137nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429893(CHEMBL2333373)
Affinity DataIC50:  238nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429892(CHEMBL2333374)
Affinity DataIC50:  259nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429891(CHEMBL2333366)
Affinity DataIC50:  398nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429890(CHEMBL2331575)
Affinity DataIC50:  459nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429889(CHEMBL2332922)
Affinity DataIC50:  670nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429888(CHEMBL2332929)
Affinity DataIC50:  693nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429887(CHEMBL2332928)
Affinity DataIC50:  705nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429886(CHEMBL2332920)
Affinity DataIC50:  763nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429885(CHEMBL2333378)
Affinity DataIC50:  1.05E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429884(CHEMBL2332921)
Affinity DataIC50:  1.09E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429883(CHEMBL2332919)
Affinity DataIC50:  1.09E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429882(CHEMBL2333372)
Affinity DataIC50:  1.13E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429881(CHEMBL2333370)
Affinity DataIC50:  1.46E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429880(CHEMBL2333376)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429879(CHEMBL2332923)
Affinity DataIC50:  2.17E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429878(CHEMBL2333371)
Affinity DataIC50:  2.31E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429877(CHEMBL2333362)
Affinity DataIC50:  2.34E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429876(CHEMBL2333377)
Affinity DataIC50:  2.45E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429875(CHEMBL2333364)
Affinity DataIC50:  2.90E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429874(CHEMBL2332924)
Affinity DataIC50: >3.00E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429873(CHEMBL2332925)
Affinity DataIC50: >3.00E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429872(CHEMBL2332926)
Affinity DataIC50: >3.00E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50429871(CHEMBL2332927)
Affinity DataIC50: >3.00E+3nMAssay Description:Inhibition of PI3Kalpha (unknown origin) using PIP2 as substrate after 2 hrs by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 194 total ) | Next | Last >>
Jump to: